Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
5 things to know before the stock market opens Monday
August 05, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
From CNBC.com News
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free